Summarized by Masters of Longevity from Startupticker.ch.
Roundup of six life sciences startups hitting clinical, regulatory, partnership, and deployment milestones across therapeutics, diagnostics, and medtech.
Key Takeaways
- Legacy Healthcare received FDA Breakthrough Therapy designation for its botanical cutaneous treatment for moderate-to-severe alopecia areata.
- BioVersys published two Phase 1 pharmacology papers for BV100, supporting its recently granted FDA Fast Track status.
- Tivenix expanded a strategic partnership with CellCarta to run clinical studies and offer its epigenetic cfDNA platform commercially.
